NYSE:ATNM

Actinium Pharmaceuticals Stock News

Healthcare > Biotechnology

Buy ATNM

*Your capital is at risk

$1.11

-0.0500 (-4.31%)

At Close: Jun 04, 2026

The Schall Law Firm Is Looking Into Whether Actinium Pharmaceuticals Inc. Violated Securities Regulations And Stockholders Should Reach Out

11:00am, Monday, 02'nd Sep 2024

LOS ANGELES, CA / ACCESSWIRE / September 2, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Actinium Phar

Actinium Pharmaceuticals Inc May Have Committed Securities Related Infractions And Investors Are Invited To Participate In The Schall Law Firm's Inquiry

11:00am, Sunday, 01'st Sep 2024

LOS ANGELES, CA / ACCESSWIRE / September 1, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Actinium Phar

Shareholders Who Have Been Affected By Actinium Pharmaceuticals Inc.'s Possible Securities Law Violations Should Join The Schall Law Firm's Investigation

11:00am, Saturday, 31'st Aug 2024

LOS ANGELES, CA / ACCESSWIRE / August 31, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Actinium Pharma

Actinium Pharmaceuticals Inc May Have Committed Securities Fraud And The Schall Law Firm Wants Impacted Investors To Reach Out About An Inquiry

11:00am, Friday, 30'th Aug 2024

LOS ANGELES, CA / ACCESSWIRE / August 30, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Actinium Pharma

The Public Is Urged To Join The Schall Law Firm In Investigating Actinium Pharmaceuticals Inc. For Possible Securities Law Violations

11:00am, Thursday, 29'th Aug 2024

LOS ANGELES, CA / ACCESSWIRE / August 29, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Actinium Pharma

An Inquiry Has Been Launched Into Whether Actinium Pharmaceuticals Inc Committed Securities Law Violations And The Schall Law Firm Seeks Investors' Help

11:00am, Wednesday, 28'th Aug 2024

LOS ANGELES, CA / ACCESSWIRE / August 28, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Actinium Pharma

The Schall Law Firm Invites Actinium Pharmaceuticals Stakeholders To Participate In A Securities Fraud Investigation

11:00am, Tuesday, 27'th Aug 2024

LOS ANGELES, CA / ACCESSWIRE / August 27, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Actinium Pharma

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Actinium Pharmaceuticals, Inc. - ATNM

08:38pm, Monday, 26'th Aug 2024

NEW YORK , Aug. 26, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Actinium Pharmaceuticals, Inc. ("Actinium" or the "Company") (NYSE: ATNM). Such investors are a

Shareholders In Actinium Pharmaceuticals Inc. Are Urged To Join The Schall Law Firm In An Inquiry Into Possible Securities Law Infractions

11:00am, Monday, 26'th Aug 2024

LOS ANGELES, CA / ACCESSWIRE / August 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Actinium Pharma

The Schall Law Firm Is Investigating Actinium Pharmaceuticals Inc. For Potential Securities Fraud And Investors With Losses Are Encouraged To Take Part

11:00am, Sunday, 25'th Aug 2024

LOS ANGELES, CA / ACCESSWIRE / August 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Actinium Pharma

The Schall Law Firm Is Investigating Actinium Pharmaceuticals Inc For Securities Fraud And Investors Are Encouraged To Participate

11:00am, Saturday, 24'th Aug 2024

LOS ANGELES, CA / ACCESSWIRE / August 24, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Actinium Pharma

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Actinium Pharmaceuticals, Inc. - ATNM

09:40am, Saturday, 24'th Aug 2024

NEW YORK, NY / ACCESSWIRE / August 24, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Actinium Pharmaceuticals, Inc. ("Actinium" or the "Company") (NYSE: ATNM). Such investors

Actinium Pharmaceuticals Inc Is Being Looked Into By The Schall Law Firm For Possible Securities Law Violations And Stockholders Are Urged To Reach Out

11:00am, Friday, 23'rd Aug 2024

LOS ANGELES, CA / ACCESSWIRE / August 23, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Actinium Pharma

Investors With Losses In Actinium Pharmaceuticals Inc Are Encouraged To Join An Investigation Into Securities Fraud With The Schall Law Firm

11:00am, Thursday, 22'nd Aug 2024

LOS ANGELES, CA / ACCESSWIRE / August 22, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Actinium Pharma

ATNM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Actinium Pharmaceuticals, Inc. and Encourages Shareholders to Contact the Firm Today!

10:00am, Thursday, 22'nd Aug 2024

NEW YORK, NY / ACCESSWIRE / August 22, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Actinium Pharmaceuticals, Inc. ("Actinium" or "the Company

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by